MeSH term
Frequency | Condition_Probility | Aged | 8 | 0.0 |
Aged, 80 and over | 2 | 0.0 |
Female | 22 | 0.0 |
Humans | 71 | 0.0 |
Animals | 10 | 0.0 |
Antibodies, Monoclonal | 2 | 0.0 |
*Cytotoxicity, Immunologic | 2 | 0.0 |
Flow Cytometry | 3 | 0.0 |
Gene Expression | 2 | 0.0 |
Killer Cells, Natural/*immunology | 4 | 0.0 |
Mice | 7 | 0.0 |
Research Support, Non-U.S. Gov't | 52 | 0.0 |
Transfection | 2 | 0.0 |
Adult | 14 | 0.0 |
Behcet Syndrome/*genetics | 3 | 13.0 |
Genetic Predisposition to Disease | 12 | 0.0 |
HLA-B Antigens/*genetics | 12 | 4.0 |
Histocompatibility Antigens Class I/*genetics | 40 | 12.0 |
Microsatellite Repeats | 7 | 0.0 |
Middle Aged | 12 | 0.0 |
Phenotype | 8 | 0.0 |
*Polymorphism, Genetic | 15 | 0.0 |
Age of Onset | 3 | 0.0 |
Alleles | 24 | 0.0 |
Genetic Predisposition to Disease/*genetics | 2 | 0.0 |
Adolescent | 4 | 0.0 |
Gene Frequency | 16 | 0.0 |
Genes, MHC Class I | 2 | 1.0 |
*Genetic Predisposition to Disease | 2 | 0.0 |
Tumor Necrosis Factor-alpha/*genetics | 2 | 0.0 |
*Antigens, Ly | 2 | 20.0 |
Models, Molecular | 4 | 0.0 |
Protein Structure, Tertiary | 2 | 0.0 |
Evolution, Molecular | 3 | 0.0 |
Heterozygote | 3 | 0.0 |
*Selection (Genetics) | 2 | 3.0 |
*Variation (Genetics) | 2 | 0.0 |
Base Sequence | 9 | 0.0 |
Haplotypes | 6 | 0.0 |
*Linkage Disequilibrium | 3 | 1.0 |
Molecular Sequence Data | 12 | 0.0 |
Polymorphism, Genetic | 14 | 0.0 |
Cell Line | 7 | 0.0 |
Hela Cells | 2 | 0.0 |
*Alleles | 7 | 0.0 |
Polymorphism, Genetic/*genetics | 5 | 0.0 |
Sequence Homology, Nucleic Acid | 4 | 0.0 |
Amino Acid Sequence | 5 | 0.0 |
Sequence Homology, Amino Acid | 5 | 0.0 |
Signal Transduction | 2 | 0.0 |
Celiac Disease/*genetics | 2 | 7.0 |
*Genes, MHC Class I | 5 | 1.0 |
Linkage Disequilibrium | 10 | 1.0 |
Male | 20 | 0.0 |
Immunohistochemistry | 2 | 0.0 |
Transplantation, Homologous | 2 | 0.0 |
Colitis, Ulcerative/*genetics | 2 | 7.0 |
Comparative Study | 5 | 0.0 |
Haplotypes/genetics | 2 | 0.0 |
Case-Control Studies | 4 | 0.0 |
HLA-DR Antigens/genetics | 2 | 0.0 |
Japan | 2 | 0.0 |
Trinucleotide Repeats | 5 | 4.0 |
Exons/*genetics | 2 | 0.0 |
HLA-B Antigens/genetics | 8 | 3.0 |
HLA-B27 Antigen/*genetics | 2 | 10.0 |
Ligands | 3 | 0.0 |
Membrane Proteins/*metabolism | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 5 | 0.0 |
Genetics, Population | 3 | 0.0 |
DNA/analysis | 2 | 0.0 |
Haplotypes/*genetics | 3 | 1.0 |
Polymerase Chain Reaction | 8 | 0.0 |
HLA-C Antigens/*genetics | 3 | 4.0 |
Tumor Necrosis Factor-alpha/genetics | 3 | 1.0 |
Histocompatibility Antigens Class I/classification/*genetics | 2 | 18.0 |
Histocompatibility Testing | 3 | 0.0 |
Polymerase Chain Reaction/methods | 2 | 0.0 |
Polymorphism, Single-Stranded Conformational | 3 | 0.0 |
Histocompatibility Antigens Class I/*biosynthesis/genetics | 2 | 18.0 |
Reverse Transcriptase Polymerase Chain Reaction | 3 | 0.0 |
Membrane Proteins/*genetics | 5 | 0.0 |
Child | 3 | 0.0 |
Genes, MHC Class I/*genetics | 3 | 4.0 |
Trinucleotide Repeats/*genetics | 2 | 2.0 |
Asian Continental Ancestry Group/genetics | 3 | 0.0 |
Gene Deletion | 2 | 0.0 |
*Gene Frequency | 2 | 0.0 |
China | 2 | 0.0 |
Membrane Proteins/genetics | 5 | 1.0 |
Child, Preschool | 2 | 0.0 |
Genotype | 8 | 0.0 |
*Evolution, Molecular | 2 | 0.0 |
Proteins/*genetics | 2 | 0.0 |
HLA-DQ Antigens/genetics | 3 | 1.0 |
Histocompatibility Antigens Class I/genetics | 2 | 2.0 |
Polymorphism, Single Nucleotide | 2 | 0.0 |
*Phylogeny | 2 | 1.0 |
Sequence Alignment | 2 | 0.0 |
Microsatellite Repeats/genetics | 2 | 0.0 |
Mice, Transgenic | 2 | 0.0 |
Sequence Analysis, DNA | 2 | 0.0 |
Risk | 2 | 0.0 |
HLA-DR Antigens/*genetics | 2 | 0.0 |
*Haplotypes | 3 | 1.0 |
